Clinical trial

Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction

NCT03506412

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-06-25

PhasePHASE4

Study timeline

Study start (actual)2018-06-25Date precision: day

Registry last updated2022-02-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Preserved Ejection Fractionunresolved

Interventions

Entresto™ 49Mg-51 mg tabletDRUG

Sponsors & collaborators

Mayo Cliniclead sponsor

National Institute on Aging (NIA)collaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03506412 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.